Bio-Rad Laboratories Inc (United States) is listed on the Nasdaq and has a market capitalization of $9.88 billion, with shareholders equity totaling $7.60 billion.
The company employs approximately 7.450 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Bio-Rad Laboratories Inc reported $2.59 billion in revenue, generating net income of $1.15 billion.
Key financial metrics include a P/E ratio of 8.56, a price-to-book (P/B) ratio of 1.30, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BIO.